NCT04366765View on ClinicalTrials.gov

COVID-19 Survival - The COVIVA Study

CompletedOBSERVATIONAL

Enrollment

1,325

Participants

Timeline

Start Date

March 19, 2020

Primary Completion Date

January 5, 2021

Study Completion Date

June 30, 2021

Conditions

COVID-19SARS-CoV 2

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT04366765 - COVID-19 Survival - The COVIVA Study | Biotech Hunter | Biotech Hunter